Portfolio
Vivalyx announces First-in-Human use of Vivalyx Omnisol® in kidney transplant clinical trial
17.03.2026
Our progress journal.
Portfolio
Portfolio company Corporis Medical begins patient enrolment in clinical investigation of Laprixa
16.03.2026
Portfolio
Psylaris: bringing VR-powered trauma therapy to Ukraine
26.02.2026
Portfolio
PectCof (NL) secures a positive EFSA scientific opinion for Dutch Gum as a novel food ingredient
27.01.2026
Portfolio
Matisse Pharmaceuticals receives INN isupartob sodium recognizing first-in-class drug status for M6229
11.12.2025
Portfolio
Lely invests in Dutch scale-up Grassa
09.12.2025
Portfolio
Exit: Fortimedix Surgical acquired by Medtronic
01.12.2025
Portfolio
Curapath and Cristal Therapeutics Sign Co-Exclusive License of CliCr® Bioconjugation Platform
26.11.2025
Portfolio
Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers
13.11.2025
Portfolio
Qorium secures €22m investment to accelerate cultivated leather commercialisation
11.11.2025
Portfolio
Matisse Pharmaceuticals & EpiDisease receive EU funding for their eHISTOCURE project
26.06.2025
Portfolio
Hy2Care secures €4.5 million in funding to prepare for U.S. clinical trial and commercial expansion
14.05.2025
Portfolio
Hy2Care® received FDA IDE approval to launch U.S. clinical trial for cartilage repair implant
17.04.2025
Portfolio
Grassa Raises €3.6M; Grass Protein Consumption by Humans Draws Closer
19.03.2025
Portfolio
Vivalyx Backed by EIC Accelerator with up to €8.5M to Advance Organ Revitalization Technology
19.02.2025
Portfolio
Matisse Pharmaceuticals receives BfArM approval to study a prolonged infusion of M6229
24.10.2024
Portfolio
Matisse Pharmaceuticals appoints Prof. Carolyn Calfee to the Scientific Board
22.10.2024
Portfolio
Bio-Engineering scale-up Qorium unveils cultivated leather breakthrough, marking major progress toward commercialization
15.10.2024
Portfolio
PL BioScience closes €7.8M Series A Financing
08.08.2024
Portfolio
Vivalyx secures seed financing to improve donor organ quality
30.04.2024
Portfolio
Funding for TripleMed to achieve CE marking
21.03.2024
Portfolio
Matisse Pharmaceuticals meets primary objectives in study with M6229 in critically ill sepsis patients
30.01.2024
Portfolio
Verdify secures €2.4 million investment for impactful food choices in healthcare and retail
24.01.2024
Portfolio
Funding of Ioniqa’s enhanced recycling business of PET Polyester
23.01.2024